Merck’s $1.3bn bet on cancer therapy: Inside the Modifi Biosciences acquisition
Merck & Co., a global leader in pharmaceuticals, has acquired Modifi Biosciences, a cutting-edge biotech startup based in New Haven, Connecticut, for up to $1.3 billion. The agreement, which involves an upfront payment of $30 million, includes milestone-dependent payouts that could total over a billion dollars. This acquisition marks Merck’s latest move to expand its […]